Analysis of benign prostatic obstruction surgery: A long-term evaluation in a real-life context

Arch Ital Urol Androl. 2022 Sep 26;94(3):295-299. doi: 10.4081/aiua.2022.3.295.

Abstract

Objective: Surgery is the treatment for male lower urinary tract symptoms (LUTS) relat-ed to benign prostatic obstruction (BPO) refractory to pharma-cological treatment or with complications. This study aimed to assess factors associated with the need for surgical reinterven-tion and/or continuation of pharmacological treatment.

Materials and methods: A retrospective analysis of patients who underwent prostatic surgery for male LUTS associated with BPO between 1 May 2015 and 1 May 2016, with a minimum follow-up of five years, in an academic tertiary hospital. The type of surgery, preoperative, postoperative and follow-up analysis were collected in a database.

Results: A total of 212 patients were included with a mean age of 70 ± 8.66 years at five years follow-up. At 5 years, a total of 86.9% of patients do not need pharmacological treatment and 12% required surgical reintervention. Of the preoperative parameters, it was found a relationship between prior prostatitis and the need for second surgery with an odds ratio of 4.6.

Conclusions: Patients should be informed of the potential need for pharmacological treatment following surgery, or even of the need for reintervention. History of prostatitis seems to be a risk factor for reintervention.

MeSH terms

  • Aged
  • Humans
  • Lower Urinary Tract Symptoms* / etiology
  • Lower Urinary Tract Symptoms* / surgery
  • Male
  • Middle Aged
  • Prostatic Hyperplasia* / complications
  • Prostatic Hyperplasia* / drug therapy
  • Prostatic Hyperplasia* / surgery
  • Prostatitis* / complications
  • Retrospective Studies
  • Urethral Obstruction*